These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1964216)

  • 1. [The possible sources of hyperandrogenism in hirsutism in girls].
    Semicheva TV; Kolesnikova GS; Pishchulin AA; Pankova SS; Dobracheva AD; Martysh NS
    Probl Endokrinol (Mosk); 1990; 36(5):53-5. PubMed ID: 1964216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism].
    Maleeva A; Milkov V; Visheva N; Kekhaĭova M
    Vutr Boles; 1990; 29(3):93-9. PubMed ID: 2178292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
    Bardin CW; Hembree WC; Lipsett MB
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
    Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperandrogenism. Tests that simplify evaluation.
    Hammond MG; Talbert LM; Groff TR
    Postgrad Med; 1986 Feb; 79(3):107-13. PubMed ID: 3003722
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal aspects in the diagnosis of hirsutism].
    Maleev A; Milkov V
    Akush Ginekol (Sofiia); 1989; 28(1):60-6. PubMed ID: 2742087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
    Lisse K; Schürenkämper P; Friedrich W; Rutkowsky J
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
    Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACTH-dependency of hirsutism; significance and critical aspects of function tests].
    Radian N; Ciocîrdia C; Tache A; Cristoveanu A; Bunea M; Panatiu G; Marinescu I
    Endocrinologie; 1978; 16(2):116-27. PubMed ID: 209528
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hirsutism and androgenic menstrual cycle irregularities].
    Carol W; Wilke I
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):153-7. PubMed ID: 2058208
    [No Abstract]   [Full Text] [Related]  

  • 14. [Critical study of the characterization of hyperandrogenism in a group of obese women].
    Cordray JP; Merceron RE; Nys P; Guillerd X; Reboul P; Rainaut M
    Rev Fr Gynecol Obstet; 1995 Oct; 90(10):403-8. PubMed ID: 8539505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.
    Coskun A; Ercan O; Arikan DC; Özer A; Kilinc M; Kiran G; Kostu B
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):167-71. PubMed ID: 21041013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androgens in the plasma of women with hirsutism (author's transl)].
    Demisch K; Magnet W; Neubauer M; Schöffling K
    Dtsch Med Wochenschr; 1975 May; 100(20):1117-23. PubMed ID: 123849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL; Horton N; Rittmaster RS
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.
    Hudson RW; Lochnan HA; Danby FW; Margesson LJ; Strang BK; Kimmett SM
    Fertil Steril; 1990 Dec; 54(6):1065-71. PubMed ID: 2174005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D; Kristesashvili J
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.